Approximately 9,000 to 10,000 people live with Amyotrophic Lateral Sclerosis (ALS) in Japan, with roughly 3,000 new patients diagnosed annually
. It is a rapidly progressive neurodegenerative disease, leading to death—often from respiratory failure—typically within three to five years. Mortality rates have seen small increases, particularly in those over 70.